SC 13G

13G/A

Company: Coeptis Therapeutics Holdings, Inc.
Filed: February 8, 2021
Accession Number: 0001600344-21-000005

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →

View Document ↗ View on SEC.gov ↗